Close Menu

NEW YORK — The US Food and Drug Administration on Thursday granted Emergency Use Authorization for the University of Nebraska Medical Center's PCR-based test for SARS-CoV-2.

The NEcov19 RT-PCR Assay is designed to detect a nucleic acid sequence from the SARS-CoV-2 E gene in nasopharyngeal, oropharyngeal, anterior nasal, and mid-turbinate swabs, as well as nasal washes, nasal aspirates, and bronchoalveolar lavage specimens.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.


This webinar will describe a rapid metagenomics assay under development for human pathogens, including the SARS-CoV-2 coronavirus.

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.


This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.